Page last updated: 2024-11-05

tripelennamine and Experimental Hepatoma

tripelennamine has been researched along with Experimental Hepatoma in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habs, M1
Shubik, P1
Eisenbrand, G1

Other Studies

1 other study available for tripelennamine and Experimental Hepatoma

ArticleYear
Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats.
    Journal of cancer research and clinical oncology, 1986, Volume: 111, Issue:1

    Topics: Adenoma; Adrenal Gland Neoplasms; Aminopyridines; Animals; Dose-Response Relationship, Drug; Female;

1986
chemdatabank.com